Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Nebulization Therapy for Lung Cancer


Affiliations
1 Arihant School of Pharmacy and BRI, Uvarsad Square, Sarkhej Gandhinagar Highway, Adalaj, Gandhinagar-382421, India
     

   Subscribe/Renew Journal


Cancer is the most leading cause of death worldwide. It is the disease in which abnormal cells divide uncontrollably and destroy body’s tissue. Cancer, also called malignancy, is the spread of abnormal cells that can infiltrate the normal body tissues. There are more than 100 types of cancer including lung cancer, blood cancer, breast cancer, colon cancer, prostate cancer, skin cancer, lymphoma etc. Among these, Lung cancer is one of the most common and serious cancers in the world. It is the uncontrollable growth of abnormal cells that start off in one or both the lungs, usually in the cells that line the air passages. The anticancer drugs used not only affect the tumor cells but even the normal body cells. Treating lung cancer using various methods such as radiations, chemotherapy, surgery till now, has various side effects of hair loss, heart problems, kidney and liver problems, fatigue, nausea, vomiting etc. Therefore, there arises a need of some targeted drug delivery system which minimizes the side effects of the drug on lungs and acts only at the tumor site. One such targeted drug delivery system is “Nebulization Chemotherapy”. It is the inhalation therapy through which the anticancer drug reaches to the tumor site in lungs, kills the cancerous cells without affecting the normal body cells and excretes out of the body. Here, the anticancer drug is inhaled as aerosols so that the drug can easily accumulate in the alveoli in lung. The inhaler therapy using nebulizer commonly used for local and systemic drug delivery of drug through lungs is promising now days. Inhalation therapy using nebulizer has several advantages like large dose can be administered, quick action, easy and convenient administration of the drug. Nebulizer uses oxygen, compressed air or ultrasonic powder to break up medical solutions and suspensions into small aerosol droplet called mists that can be directly inhaled from the mouthpiece of the device. Thus, the near future needs nebulization chemotherapy as the targeted drug delivery system as the new cure of lung cancer. It would be a breakthrough innovation in the treatment of lung cancer.

Keywords

Lung, Cancer, Nebulization, Chemotheraphy, Aerosols, Targeted Drug Delivery.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Kardinal C, Yarbro JA. “Conceptual history of cancer”. Semin Oncol 1979; 6:396–408

  • Union for International Cancer Control • Union Internationale Contre le Cancer; “Cancer Explained”; January 2013

  • Akulapalli Sudhakar et al” History of Cancer, Ancient and Modern Treatment Methods”; J Cancer Sci Ther. 2009 December 1; 1(2)

  • https://www.news-medical.net/health/Cancer-Classification.aspx 3/7/18 11:04

  • Goldstraw P, et al. “The Iaslc Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours”. J Thorac Oncol Volume 2, Issue 8 706–714

  • Boyle P, Maisonneuve P (1995)” Lung cancer and tobacco smoking”. Lung Cancer, 12: 167-181.

  • Stellman SD, Resnicow K (1997) Tobacco smoking, cancer and social class. In: Kogevinas M, Pearce N, Susser M and Boffetta P, eds,” Social Inequalities and Cancer”, (IARC Scientific Publications, No. 138), Lyon, IARCPress, 229-250.

  • Potter JD, ed. (1997) Food, Nutrition and the Prevention of Cancer: a Global Perspective, Washington, DC, American Institute for Cancer Research.

  • World Health Organization (1999) Global Status Report on Alcohol, Geneva, WHO.

  • Bandera EV, Freudenheim JL, Vena JE (2001)” Alcohol consumption and lung cancer: a review of the epidemiologic evidence”. Cancer Epidemiol Biomarkers Prev, 10:813-821.

  • IARC (1988) Alcohol Drinking (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 44), Lyon, IARCPress.

  • IARC (1972-2001) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vols 1-78, Lyon, IARCPress.

  • IARC (2002) Man-made Vitreous Fibres, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 81, Lyon, IARCPress.

  • Tomatis L, Aitio A, Day NE, Heseltine E, Kaldor J, Miller AB, Parkin DM, Riboli E, eds (1990) Cancer: Causes, Occurrence and Control (IARC Scientific Publications, No.100), Lyon, IARC Press .

  • Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst, 66: 1191-1308..

  • United Nations Scientific Committee on the Effects of Atomic Radiation (2000) Sources and Effects of Ionizing Radiation: 2000 Report, Vienna, UNSCEAR.

  • International Commission on Radiological Protection (1991) Recommendations of the International Commission on Radiological Protection (ICRP Report 60), Oxford, Pergamon Press.

  • Lung Cancer Overview; 2005 Nucleus Medical Art (www.nucleusinc.com) ;viewed on 10/04/18

  • Jenny Mothoneos.” Understanding Lung Cancer A guide for people with cancer, their families and friends”; Cancer Council Australia 2016; Cancer Council Australia 2016

  • Australian Institute of Health and Welfare (AIHW), Cancer in Australia: an overview 2014, AIHW, Canberra, 2014.4

  • Australian Institute of Health and Welfare (AIHW), Australian Cancer Incidence and Mortality (ACIM) books: Lung cancer, AIHW, Canberra, 2016

  • Cancer Council Australia Lung Cancer Guidelines Working Party, Clinical practice guidelines for the treatment of lung cancer, Cancer Council Australia, Sydney [cited 2016]. Available from: http://wiki.cancer.org.au/australia/Guidelines:Lung_cancer.

  • Timeline: Milestones in cancer treatment. CureToday. 2009. Web site accessed at: http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/631

  • Progress against cancer. 2009. Web site accessed at:

  • http://www.cancer.net/patient/Advocacy%20and%20Policy/Treatment_Advances_Timeline.pdf

  • Bart P.H.Wittgen, Peter W.A. Kunst, Kasper van der Born, Atie W. van Wijk, Walter Perkins, Frank G. Pilkiewicz, Roman Perez-Soler, Susan Nicholson, GodefridusJ. Peters, and Pieter E. Postmus.” Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung”; Clin Cancer Res 2007;13(8) April 15, 2007; Downloaded from clincancerres.aacrjournals.org on February 9, 2018. © 2007 American Association for cancer research.

  • Santosh Thorat. “Formulation and Product Development of Nebuliser Inhaler”; An Overview International Journal of Pharmaceutical Science and Research ISSN: 2455-4685, Impact Factor: RJIF 5.28 www.pharmacyjournal.net Volume 1; Issue 5; July 2016; Page No. 30-35

  • Anderson PM, Markovic SN, Sloan JA, et al. Aerosolgranulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. Clin Cancer Res 1999; 5:2316 ^ 23.

  • Rakesh Pahwa1, Pankaj, Manisha Singh, Mona Piplani1 and Avneet Kaur Lamba. “Nebulizer Therapy: A Platform for Pulmonary Drug Delivery”; Pelagia Research LibraryDer Pharmacia Sinica, 2012, 3 (6):630-636

  • Mark Copley, Copley Scientific.” Nebulizer testing Exploring the implications ofnew regulatory guidance for testing nebulizers”;WWW.INHALATIONMAG.COM; As appeared in Inhalation, OCTOBER 2008 30 https://justnebulizers.com/general-nebulizer-information/ 3/7/18

  • frederic gagnadoux, jose hureaux, laurent vecellio, thierry urban, alain le pape, isabelle valo, jerome montharu, valerie leblond, michele boisdron-celle, stephanie lerondel, caroline majoral, patrice diot, jean. racineux,and etienne lemarie. “aerosolized chemotherapy”; journal of aerosol medicine and pulmonary drug delivery ;volume 21, number 1, 2008© mary ann liebert, inc.pp. 61–69doi: 10.1089/jamp.2007.0656

  • Paul Zarogoulidis, Ekaterini Chatzaki, Konstantinos Porpodis, Kalliopi Domvri, Wolfgang Hohenforst-Schmidt Eugene P Goldberg, Nikos Karamans, Konstantinos Zarogoulidis.” Inhaled chemotherapy in lung cancer: future concept of nanomedicine” ;dove press journal; International journal of nanomedicine;21 march 2012;2012:7 1551–1572; 2012 Zarogoulidis et al

  • Mukesh K. Nag, Satish Patel, Rajnikant Panik, Shikha Shrivastava, Sanjay J. Daharwal, Manju R. Singh, Deependra Singh.” Lung Cancer Targeting: A Review”. Research J. Pharm. and Tech. 6(11): November 2013; Page 1302-1306.

  • Kumbhar Swapnil, Salunkhe Vijay , Magdum Chandrakant.” Targeted Drug Delivery: A Backbone for Cancer Therapy”. Asian J. Pharm. Res. 3(1): Jan.-Mar. 2013; Page 40-46.

  • Deepak Rao Khadatkar, Yogesh Rathore .” An Efficient and Useful Hybrid Approach for Detection of Lung Cancer”. Research J. Engineering and Tech. 2(4):Oct.-Dec. 2011 page199-202.

  • Dibyajyoti Saha, Tarashankar Maity, Mayukh Jana, Supradip Mandal. “Cancer Treatment Strategy-An Overview. Asian J. Pharm. Tech”. 1(2): April-June 2011; Page 28-33.

  • Sedigheh Iranmanesh, Ala Shamsi. “The Relationship between Type of Cancer and Parent's Psychosocial Risks”. Asian J. Nur. Edu. and Research 4(4): Oct.- Dec., 2014; Page 495-501.

  • Poonam Gupta, Mohd. Yaqub Khan, Vikas Kumar Verma, Ashish Pathak.” Beating Cancer with Natural Plant Sources”. Asian J. Pharm. Tech. 3(2): April-June. 2013; Page 39-44.

  • Namrata Dwivedi, Bhavna Dwivedi, Skand Mishra, Yogeshwer Shukla.” Lupeol Induced Apoptosis in Human Lung Cancer Cell Line: A Flow Cytometry Study”. Research Journal of Pharmacology and Pharmacodynamics. 2014; 6(4): 197-203.

  • C. H. Praveena, K. Pramod, K. C. Ajithkumar.” Dendritic cell vaccine for cancer therapy”. Res. J. Pharmacology & Pharmacodynamics.2016; 8(3): 141-147.

  • Swati Patil, S R Naik, V Joshi, CI Jolly, S Narayanan.” Effect of Acacia catechu and Rotula aquatica on the DNA: Implications for cancer therapy”. Research J. Pharmacology and Pharmacodynamics. 2009; 1(1): 31-34.

  • Chandrasekar. R, Sivagami. B, M. Niranjan Babu.” A Pharmacoeconomic Focus on Medicinal Plants with Anticancer Activity”. Res. J. Pharmacognosy and Phytochem. 2018; 10(1): 91-100.


Abstract Views: 218

PDF Views: 0




  • Nebulization Therapy for Lung Cancer

Abstract Views: 218  |  PDF Views: 0

Authors

Shukla Maitri Jayeshkumar
Arihant School of Pharmacy and BRI, Uvarsad Square, Sarkhej Gandhinagar Highway, Adalaj, Gandhinagar-382421, India
Patel Yashvi
Arihant School of Pharmacy and BRI, Uvarsad Square, Sarkhej Gandhinagar Highway, Adalaj, Gandhinagar-382421, India
Bhavin Bhimani
Arihant School of Pharmacy and BRI, Uvarsad Square, Sarkhej Gandhinagar Highway, Adalaj, Gandhinagar-382421, India
Ghanshyam Patel
Arihant School of Pharmacy and BRI, Uvarsad Square, Sarkhej Gandhinagar Highway, Adalaj, Gandhinagar-382421, India
Jaimin Patel
Arihant School of Pharmacy and BRI, Uvarsad Square, Sarkhej Gandhinagar Highway, Adalaj, Gandhinagar-382421, India
Upendra Patel
Arihant School of Pharmacy and BRI, Uvarsad Square, Sarkhej Gandhinagar Highway, Adalaj, Gandhinagar-382421, India

Abstract


Cancer is the most leading cause of death worldwide. It is the disease in which abnormal cells divide uncontrollably and destroy body’s tissue. Cancer, also called malignancy, is the spread of abnormal cells that can infiltrate the normal body tissues. There are more than 100 types of cancer including lung cancer, blood cancer, breast cancer, colon cancer, prostate cancer, skin cancer, lymphoma etc. Among these, Lung cancer is one of the most common and serious cancers in the world. It is the uncontrollable growth of abnormal cells that start off in one or both the lungs, usually in the cells that line the air passages. The anticancer drugs used not only affect the tumor cells but even the normal body cells. Treating lung cancer using various methods such as radiations, chemotherapy, surgery till now, has various side effects of hair loss, heart problems, kidney and liver problems, fatigue, nausea, vomiting etc. Therefore, there arises a need of some targeted drug delivery system which minimizes the side effects of the drug on lungs and acts only at the tumor site. One such targeted drug delivery system is “Nebulization Chemotherapy”. It is the inhalation therapy through which the anticancer drug reaches to the tumor site in lungs, kills the cancerous cells without affecting the normal body cells and excretes out of the body. Here, the anticancer drug is inhaled as aerosols so that the drug can easily accumulate in the alveoli in lung. The inhaler therapy using nebulizer commonly used for local and systemic drug delivery of drug through lungs is promising now days. Inhalation therapy using nebulizer has several advantages like large dose can be administered, quick action, easy and convenient administration of the drug. Nebulizer uses oxygen, compressed air or ultrasonic powder to break up medical solutions and suspensions into small aerosol droplet called mists that can be directly inhaled from the mouthpiece of the device. Thus, the near future needs nebulization chemotherapy as the targeted drug delivery system as the new cure of lung cancer. It would be a breakthrough innovation in the treatment of lung cancer.

Keywords


Lung, Cancer, Nebulization, Chemotheraphy, Aerosols, Targeted Drug Delivery.

References